Today: 22 May 2026
Robinhood stock snaps back as HOOD heads into earnings after a rough week
6 February 2026
2 mins read

Robinhood stock snaps back as HOOD heads into earnings after a rough week

NEW YORK, February 6, 2026, 10:51 EST

  • Shares of Robinhood jumped roughly 13% in early trading following a steep decline, ahead of earnings due February 10.
  • A Zacks note pointed out that HOOD is technically oversold following a steep drop of about 50% since its October peak.
  • Earlier losses stemmed from a wider tech sector shift and renewed worries over AI automation tools.

Shares of Robinhood Markets surged roughly 13% on Friday, recovering some ground after a steep drop pushed the online broker’s stock far below last year’s highs. This boost comes just days ahead of its quarterly earnings report. Nvidia shares also climbed amid a broader rally in risk-taking.

This matters since Robinhood stands as a key indicator of retail risk appetite—covering options, crypto, and other fast-turnover trades. Investors want to see if that activity sustains heading into earnings. The company is set to report on Feb. 10, and its stock decline since October has accelerated discussions around its valuation.

Robinhood dropped 8.4% Wednesday amid another selloff in growth stocks and growing concerns that new AI systems might automate tasks traditionally central to software and services firms, according to a StockStory report. The note highlighted that the stock is down roughly 30% year-to-date and has lost nearly half its value from the October 2025 peak.

On Thursday, Zacks writer Benjamin Rains noted that the recent pullback has pushed HOOD toward technical support levels that might draw buyers ahead of the Feb. 10 earnings report. Despite the drop, Robinhood’s shares have surged about 650% over the past two years. Rains highlighted that the stock is now trading at its most oversold point on the RSI, a momentum indicator popular with technical traders.

A Zacks “Investment Ideas” note on Friday reiterated that Robinhood has moved far beyond its meme-stock roots, highlighting its expansion into retirement accounts, crypto trading, futures, and prediction markets. The note also referenced Robinhood’s claim of having “11 business lines each generating ~$100 million or more in annualized revenues.” Finviz

Zacks pointed to a rise in Robinhood’s paid Gold subscribers and investment accounts in its latest quarterly report, alongside a notable boost in average revenue per user — a key metric tracking how much each customer generates. These numbers draw attention since Robinhood’s revenue tends to fluctuate with trading activity.

The note also positioned Robinhood as a growing threat to traditional brokers like Fidelity, along with public rivals Charles Schwab and Interactive Brokers, as it adds more offerings for active traders. In crypto, investors tend to treat it much like Coinbase, since both often move in sync with market sentiment.

Valuation remains the hurdle. Zacks highlighted a forward price-to-earnings ratio around 35.7 times, based on anticipated profits, and drew attention to the stock’s price/earnings-to-growth (PEG) ratio, which measures valuation against projected earnings growth.

The downside is clear. Robinhood relies heavily on customer activity, which can drop off fast when markets turn cautious. It also remains vulnerable to crypto price swings and abrupt shifts away from high-growth stocks.

The next checkpoint will be the Feb. 10 report and any guidance that comes after. Traders want to see if Robinhood’s newer offerings are stabilizing a business that’s historically swung with investor sentiment.

Stock Market Today

  • Q1 Earnings Review: Azenta Falls; West Pharmaceutical Leads Drug Development Services Stocks
    May 21, 2026, 9:31 PM EDT. Drug development inputs and services stocks, essential for pharmaceutical research and manufacturing, reported mixed Q1 results. Azenta (NASDAQ:AZTA), specializing in biological sample management, posted disappointing results with $144.8 million revenue, missing estimates and the weakest among peers, causing its share price to drop 23.4% to $17.65. Conversely, West Pharmaceutical Services (NYSE:WST), maker of specialized packaging and delivery devices, delivered a strong quarter with $844.9 million revenue, beating estimates by 8.4%. Overall, the sector's revenues beat consensus by 1.6%, despite an average 2.5% share price decline post-earnings. Tailwinds include growth in biologics and gene therapies, while headwinds feature pricing pressure and regulatory risks.

Latest articles

OpenAI Shares Hype Returns, Still No Ticker in Sight

OpenAI Shares Hype Returns, Still No Ticker in Sight

22 May 2026
OpenAI is preparing to confidentially file for a U.S. IPO, aiming to go public as early as September, sources told Reuters. The move follows a court win against Elon Musk, removing a key legal obstacle. Private-market share prices for OpenAI ranged from $658.94 to $732.38 this month, but no official public price exists. Ordinary investors still cannot buy OpenAI stock on public exchanges.
Estée Lauder Shares Gain as Rumored Deal Fails to Materialize

Estée Lauder Shares Gain as Rumored Deal Fails to Materialize

22 May 2026
Estée Lauder and Spain’s Puig ended merger talks that would have created a $40 billion beauty group. Estée Lauder shares rose about 10% in after-hours trading, closing the regular session at $78.91. The company said it will focus on its turnaround plan and continue reviewing possible acquisitions or divestitures.
WhiteFiber Stock Rips 22% on $160 Million AI Deal. The Test Comes in July

WhiteFiber Stock Rips 22% on $160 Million AI Deal. The Test Comes in July

22 May 2026
WhiteFiber shares jumped 22.2% to $29.55 after announcing a five-year AI compute contract worth over $160 million for a Paris-region deployment using NVIDIA GPU systems. Google Finance showed the stock rising further after hours. The project is backed by planned financing and 12 months of customer prepayments, but funding and execution remain pending. Service is expected to start in July, subject to equipment delivery and acceptance.
Google stock price slips as Alphabet’s AI spending push keeps GOOG in focus
Previous Story

Google stock price slips as Alphabet’s AI spending push keeps GOOG in focus

Robinhood stock jumps nearly 15% as bitcoin rebounds; earnings next week in focus
Next Story

Robinhood stock jumps nearly 15% as bitcoin rebounds; earnings next week in focus

Go toTop